Pharmacokinetics and Pharmacodynamics of Captopril in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis | Citedby Results | Nephron | Karger Publishers

Skip to Main Content

Skip Nav Destination

Pharmacokinetics and Pharmacodynamics of Captopril in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis

Nephron (1986) 44 (4): 324–328.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Risk-Benefit Ratio of Angiotensin Antagonists versus ACE Inhibitors in End-Stage Renal Disease

Domenic A. Sica
Todd W.B. Gehr
Andrea Fernandez

Drug Safety (2000) 22 (5): 350.

Practical Guidelines for Drug Therapy in Dialysis: The Pharmacokinetics of Angiotensin‐Converting Enzyme Inhibitors in End‐Stage Renal Disease

Domenic A. Sica
Todd W. B. Gehr

Seminars in Dialysis (1994) 7 (3): 205.

Pharmacokinetics and pharmacodynamics of quinaprilat after low dose quinapril in patients with terminal renal failure

K. Wolter
E. Fritschka

European Journal of Clinical Pharmacology (1993) 44 (S1): S53.